Amyotrophic Lateral Sclerosis Unfolding the Toxicity of the Misfolded

ALS-FTD and juvenile ALS cases have not yet been Amyotrophic lateral sclerosis (ALS) is one of the most identified. common adult-onset neurogenerative diseases, having In a small number of sporadic ALS patients (z1% of a prevalence of z5 per 100,000 individuals. This human cases), codon deletions or insertion in the KSP repeat disease, first described by Charcot in 1869, is charactermotif of the neurofilament NF-H gene have been identiized by the selective degeneration of motor neurons, fied (for review see Cleveland, 1999). No such NF-H the large nerve cells connecting the brain to the spinal mutants have been detected in over 1000 control DNA cord and from the spinal cord to muscles, that control samples. The combined data suggest that NF-H variants muscle movement. The loss of motor neurons leads may represent risk factors for ALS disease. to progressive atrophy of skeletal muscles. ALS is a For the vast majority of ALS cases, the factors trigrelentless disease that manifests as progressive decline gering focal initiation and then spreading of motor neuin muscular function resulting in eventual paralysis, ron degeneration in sporadic ALS remain to be elucispeech deficits and, ultimately, death due to respiratory dated. Various hypotheses have been suggested as failure in the majority of ALS patients within 2 to 5 years potential contributors of disease such as oxidative damof clinical onset. The weakness, which typically begins age, excitotoxicity, mitochondrial defects, and autoimfocally and propagates, is usually associated with the munity but these could be secondary to the neurodegendegeneration of both lower motor neurons in the braineration process. The “virus hypothesis” as primary stem and spinal cord, and upper motor neurons in the cause of ALS is now being revisited in light of a recent cerebral cortex. Approximately 10% of ALS patients are report of enterovirus (EV) nucleic acids detected by refamilial cases. The majority of ALS cases are sporadic verse transcriptase-PCR in the spinal cord of a high (90%) with no known genetic component. While current percentage of patients with sporadic ALS (Berger et al., evidence suggests that multiple genetic and environ2000). More studies are needed to confirm these results mental factors may be implicated in ALS pathogenesis, and to demonstrate that EV sequences can play a causal both sporadic and familial ALS cases share common role in ALS development. pathological features such as the presence of abnormal

[1]  J. Loeffler,et al.  Differential Screening of Mutated SOD1 Transgenic Mice Reveals Early Up-Regulation of a Fast Axonal Transport Component in Spinal Cord Motor Neurons , 2000, Neurobiology of Disease.

[2]  Q. Zhu,et al.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Julien,et al.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Cleveland From Charcot to SOD1 Mechanisms of Selective Motor Neuron Death in ALS , 1999, Neuron.

[5]  D. Cleveland,et al.  A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease , 1994, Neuron.

[6]  L. Kurland,et al.  Fine Structural Study of Neurofibrillary Changes in a Family with Amyotrophic Lateral Sclerosis , 1984, Journal of neuropathology and experimental neurology.

[7]  L. Donehower,et al.  Absence of p53: No Effect in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 2000, Experimental Neurology.

[8]  C. Gravel,et al.  Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. , 1999, Journal of neuropathology and experimental neurology.

[9]  D. Cleveland,et al.  Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Bruijn,et al.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.

[11]  M. Dubois‐Dauphin,et al.  Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. , 1997, Science.

[12]  J S Beckman,et al.  Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. , 1999, Science.

[13]  M. Dubois‐Dauphin,et al.  Bax and Bcl‐2 Interaction in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.

[14]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[15]  J. Julien,et al.  Altered Ionic Conductances in Axons of Transgenic Mouse Expressing the Human Neurofilament Heavy Gene: A Mouse Model of Amyotrophic Lateral Sclerosis , 2000, Experimental Neurology.

[16]  P. Wong,et al.  Pathogenesis of two axonopathies does not require axonal neurofilaments , 1998, Nature.

[17]  Margaret A. Johnson,et al.  Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death , 1999, Annals of neurology.

[18]  M. Mattson,et al.  The prostate apoptosis response‐4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  L. Colom,et al.  Amyotrophic Lateral Sclerosis Immunoglobulins Increase Intracellular Calcium in a Motoneuron Cell Line , 1997, Experimental Neurology.

[20]  A. Hays,et al.  Peripherin and Neurofilament Protein Coexist in Spinal Spheroids of Motor Neuron Disease , 1992, Journal of neuropathology and experimental neurology.

[21]  R. Pamphlett Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS , 2000, Neurology.

[22]  D L Price,et al.  Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Shaw,et al.  Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons , 2000, The Journal of cell biology.

[24]  M. Gurney,et al.  Intracellular Calcium Parallels Motoneuron Degeneration in SOD-1 Mutant Mice , 1998, Journal of neuropathology and experimental neurology.

[25]  Robert H. Brown,et al.  SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter , 1999, Nature Neuroscience.

[26]  M. Pericak-Vance,et al.  Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers , 1998, Neurogenetics.

[27]  V. Meininger,et al.  Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.

[28]  Robert H. Brown,et al.  Amyotrophic Lateral Sclerosis-linked Glutamate Transporter Mutant Has Impaired Glutamate Clearance Capacity* , 2001, The Journal of Biological Chemistry.

[29]  A. Hottinger,et al.  Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2. , 2000, Human molecular genetics.

[30]  D. Figlewicz,et al.  Aggregation of Mutant Cu/Zn Superoxide Dismutase Proteins in a Culture Model of ALS , 1997, Journal of neuropathology and experimental neurology.

[31]  J. Julien,et al.  Formation of Intermediate Filament Protein Aggregates with Disparate Effects in Two Transgenic Mouse Models Lacking the Neurofilament Light Subunit , 2000, The Journal of Neuroscience.

[32]  A. Levey,et al.  Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.

[33]  Lin Jin,et al.  Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis , 1998, Neuron.

[34]  L. WilliamsonT,et al.  神経フィラメントの欠如は,家族性筋萎縮性側索硬化症関連スーパオキジドジスムターゼ1変異に対する運動ニューロンの選択的易損性を低下させ,疾患を遅らせる , 1998 .

[35]  O. Andreassen,et al.  Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis , 2000, Annals of neurology.

[36]  D. Cleveland,et al.  Bcl-2 Overexpression Does Not Protect Neurons from Mutant Neurofilament-Mediated Motor Neuron Degeneration , 1999, The Journal of Neuroscience.

[37]  Robert H. Brown,et al.  Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis , 1997, Journal of neurochemistry.

[38]  N. Ende,et al.  Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). , 2000, Life sciences.

[39]  D. Bredesen,et al.  Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.

[40]  Q. Zhu,et al.  Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Haines,et al.  Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. , 2000, JAMA.

[42]  P. Couratier,et al.  In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients , 2000, Journal of Neuroimmunology.

[43]  J. Julien,et al.  Late Onset Death of Motor Neurons in Mice Overexpressing Wild-Type Peripherin , 1999, The Journal of cell biology.

[44]  D. Borchelt,et al.  Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. Spooren,et al.  DNA laddering and caspase 3-like activity in the spinal cord of a mouse model of familial amyotrophic lateral sclerosis. , 2000, Cellular and molecular biology.

[46]  L J Martin,et al.  Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. , 1999, Journal of neuropathology and experimental neurology.

[47]  M. Gurney,et al.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  O. Evgrafov,et al.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.

[49]  J. Kong,et al.  Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1 , 1998, The Journal of Neuroscience.

[50]  L. Bruijn,et al.  Toxicity of ALS-linked SOD1 mutants. , 2000, Science.

[51]  J. Haines,et al.  Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35 , 1994, Nature Genetics.

[52]  A Al-Chalabi,et al.  Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. , 1999, Human molecular genetics.

[53]  M. Gurney,et al.  Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[54]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[55]  B. Crain,et al.  Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. , 1998, American journal of human genetics.

[56]  H. Horvitz,et al.  Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis , 1998, Annals of neurology.

[57]  S. Przedborski,et al.  Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.

[58]  M. Moskowitz,et al.  Expression of a Dominant Negative Mutant of Interleukin-1β Converting Enzyme in Transgenic Mice Prevents Neuronal Cell Death Induced by Trophic Factor Withdrawal and Ischemic Brain Injury , 1997, The Journal of experimental medicine.

[59]  P. Stieg,et al.  Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. , 2000, Science.

[60]  E. Joosten,et al.  Chronic Mitochondrial Inhibition Induces Selective Motoneuron Death In Vitro: A New Model for Amyotrophic Lateral Sclerosis , 2000, Journal of neurochemistry.

[61]  Robert H. Brown,et al.  Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis , 1997, Annals of neurology.

[62]  M. Gurney,et al.  Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis , 1999, Neuroscience.

[63]  B. Lina,et al.  Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS , 2000, Neurology.

[64]  D. Schiffer,et al.  Lack of apoptosis in mice with ALS , 1999, Nature Medicine.

[65]  Guy A. Rouleau,et al.  SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .

[66]  J. Kong,et al.  Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis , 2000, Neuroscience Letters.

[67]  W. Snider,et al.  Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration , 2000, The Journal of Neuroscience.

[68]  J. Julien,et al.  Extra Axonal Neurofilaments Do Not Exacerbate Disease Caused by Mutant Cu,Zn Superoxide Dismutase , 2000, Neurobiology of Disease.

[69]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[70]  M. Strong,et al.  Nitration of the low molecular weight neurofilament is equivalent in sporadic amyotrophic lateral sclerosis and control cervical spinal cord. , 1998, Biochemical and biophysical research communications.

[71]  Georg Grön,et al.  The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals , 1999, Journal of the Neurological Sciences.

[72]  J. Kong,et al.  Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS) , 1999, Glia.

[73]  Ole A. Andreassen,et al.  Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.

[74]  M. Beal,et al.  Elevated “Hydroxyl Radical” Generation In Vivo in an Animal Model of Amyotrophic Lateral Sclerosis , 1998, Journal of neurochemistry.

[75]  M. Strong,et al.  Characterization of Neuronal Intermediate Filament Protein Expression in Cervical Spinal Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis (ALS) , 2000, Journal of neuropathology and experimental neurology.

[76]  D. Price,et al.  Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[77]  H. Horvitz,et al.  Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis , 1997, Annals of neurology.